Deuterated sigma-1 agonist showed anti-seizure activity in traumatic brain injury models

Research results published in the Journal of Neurotrauma and conducted by the Walter Reed Army Institute of Research (WRAIR) as part of a collaboration with Concert Pharmaceuticals, Inc.